144 related articles for article (PubMed ID: 35411762)
21. Glucocorticoid therapy causes contradictory changes of serum Wnt signaling-related molecules in systemic autoimmune diseases.
Kawazoe M; Kaneko K; Shikano K; Kusunoki N; Nanki T; Kawai S
Clin Rheumatol; 2018 Aug; 37(8):2169-2178. PubMed ID: 28551822
[TBL] [Abstract][Full Text] [Related]
22. The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus.
Gaudio A; Privitera F; Pulvirenti I; Canzonieri E; Rapisarda R; Fiore CE
Diab Vasc Dis Res; 2014 Jan; 11(1):48-52. PubMed ID: 24227537
[TBL] [Abstract][Full Text] [Related]
23. Correlation between sclerostin and Dickkopf-1 with aortic arterial stiffness in patients with type 2 diabetes: A prospective, cross-sectional study.
Yang HY; Wu DA; Chen MC; Hsu BG
Diab Vasc Dis Res; 2019 May; 16(3):281-288. PubMed ID: 30547685
[TBL] [Abstract][Full Text] [Related]
24. Changes of serum sclerostin and Dickkopf-1 levels during the menstrual cycle. A pilot study.
Liakou CG; Mastorakos G; Makris K; Fatouros IG; Avloniti A; Marketos H; Antoniou JD; Galanos A; Dontas I; Rizos D; Tournis S
Endocrine; 2016 Nov; 54(2):543-551. PubMed ID: 27601021
[TBL] [Abstract][Full Text] [Related]
25. Study of correlation of level of expression of Wnt signaling pathway inhibitors sclerostin and dickkopf-1 with disease activity and severity in rheumatoid arthritis patients.
Singh A; Gupta MK; Mishra SP
Drug Discov Ther; 2019; 13(1):22-27. PubMed ID: 30880318
[TBL] [Abstract][Full Text] [Related]
26. High levels of serum sclerostin and DKK1 in a case of Klippel-Trénaunay syndrome.
Muto P; Lo Gullo A; Mandraffino G; Loddo S; Atteritano M
Osteoporos Int; 2018 Jul; 29(7):1679-1681. PubMed ID: 29774401
[TBL] [Abstract][Full Text] [Related]
27. Circulating Wnt/β-catenin signalling inhibitors and uraemic vascular calcifications.
Yang CY; Chang ZF; Chau YP; Chen A; Yang WC; Yang AH; Lee OK
Nephrol Dial Transplant; 2015 Aug; 30(8):1356-63. PubMed ID: 25817223
[TBL] [Abstract][Full Text] [Related]
28. Upregulated serum sclerostin level in the T2DM patients with femur fracture inhibits the expression of bone formation/remodeling-associated biomarkers via antagonizing Wnt signaling.
Wu Y; Xu SY; Liu SY; Xu L; Deng SY; He YB; Xian SC; Liu YH; Ni GX
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):470-478. PubMed ID: 28239825
[TBL] [Abstract][Full Text] [Related]
29. Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus.
Gaudio A; Privitera F; Battaglia K; Torrisi V; Sidoti MH; Pulvirenti I; Canzonieri E; Tringali G; Fiore CE
J Clin Endocrinol Metab; 2012 Oct; 97(10):3744-50. PubMed ID: 22855334
[TBL] [Abstract][Full Text] [Related]
30. Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease.
Polyzos SA; Anastasilakis AD; Kountouras J; Makras P; Papatheodorou A; Kokkoris P; Sakellariou GT; Terpos E
J Bone Miner Metab; 2016 Jul; 34(4):447-56. PubMed ID: 26056025
[TBL] [Abstract][Full Text] [Related]
31. Circulating sclerostin and dickkopf-1 levels in ossification of the posterior longitudinal ligament of the spine.
Kashii M; Matuso Y; Sugiura T; Fujimori T; Nagamoto Y; Makino T; Kaito T; Ebina K; Iwasaki M; Yoshikawa H
J Bone Miner Metab; 2016 May; 34(3):315-24. PubMed ID: 26040409
[TBL] [Abstract][Full Text] [Related]
32. Role of sclerostin and dkk1 in bone remodeling in type 2 diabetic patients.
Wang N; Xue P; Wu X; Ma J; Wang Y; Li Y
Endocr Res; 2018 Feb; 43(1):29-38. PubMed ID: 28972408
[TBL] [Abstract][Full Text] [Related]
33. Sclerostin and DKK-1: two important regulators of bone metabolism in HIV-infected youths.
Mora S; Puzzovio M; Giacomet V; Fabiano V; Maruca K; Capelli S; Nannini P; Lombardi G; Zuccotti GV
Endocrine; 2015 Aug; 49(3):783-90. PubMed ID: 25596857
[TBL] [Abstract][Full Text] [Related]
34. Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome.
Belaya ZE; Rozhinskaya LY; Melnichenko GA; Solodovnikov AG; Dragunova NV; Iljin AV; Dzeranova LK; Dedov II
Osteoporos Int; 2013 Aug; 24(8):2191-9. PubMed ID: 23358608
[TBL] [Abstract][Full Text] [Related]
35. Sclerostin levels and changes in bone metabolism after bariatric surgery.
Muschitz C; Kocijan R; Marterer C; Nia AR; Muschitz GK; Resch H; Pietschmann P
J Clin Endocrinol Metab; 2015 Mar; 100(3):891-901. PubMed ID: 25490275
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant tamoxifen but not aromatase inhibitor therapy decreases serum levels of the Wnt inhibitor dickkopf-1 while not affecting sclerostin in breast cancer patients.
Göbel A; Kuhlmann JD; Link T; Wimberger P; Browne AJ; Rauner M; Hofbauer LC; Rachner TD
Breast Cancer Res Treat; 2017 Aug; 164(3):737-743. PubMed ID: 28526959
[TBL] [Abstract][Full Text] [Related]
37. Effect of androgen deprivation therapy on serum levels of sclerostin, Dickkopf-1, and osteoprotegerin: a cross-sectional and longitudinal analysis.
Wang A; Karunasinghe N; Plank LD; Zhu S; Osborne S; Brown C; Bishop K; Schwass T; Tijono S; Holmes M; Masters J; Huang R; Keven C; Ferguson LR; Lawrenson R
Sci Rep; 2021 Jul; 11(1):14905. PubMed ID: 34290287
[TBL] [Abstract][Full Text] [Related]
38. Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis.
Morabito N; Catalano A; Gaudio A; Morini E; Bruno LM; Basile G; Tsiantouli E; Bellone F; Agostino RM; Piraino B; La Rosa MA; Salpietro C; Lasco A
J Bone Miner Metab; 2016 Sep; 34(5):540-6. PubMed ID: 26204844
[TBL] [Abstract][Full Text] [Related]
39. Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis.
Rossini M; Viapiana O; Zanotti R; Tripi G; Perbellini O; Idolazzi L; Bonifacio M; Adami S; Gatti D
Calcif Tissue Int; 2015 May; 96(5):410-6. PubMed ID: 25694360
[TBL] [Abstract][Full Text] [Related]
40. High serum levels of sclerostin and Dickkopf-1 are associated with acute ischaemic stroke.
He XW; Wang E; Bao YY; Wang F; Zhu M; Hu XF; Jin XP
Atherosclerosis; 2016 Oct; 253():22-28. PubMed ID: 27573735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]